Sackler Family Exits Bankruptcy Trial Over Purdue Pharma's OxyContin – Bloomberg

Purdue Pharma OxyContin 
Photographer: George Frey/Bloomberg
The settlement caps years of political pressure and public outcry over the blockbuster drug OxyContin.

, and
The Sackler family made billions of dollars on Purdue Pharma LP’s blockbuster painkiller OxyContin before their name was tarnished by a staggering public-health crisis in the U.S. Now they’re quitting the drug business as part of the company’s bankruptcy settlement, which will allow them to largely preserve — and potentially grow — the bulk of their fortune, an estimated $11 billion.
On Wednesday, U.S. Bankruptcy Judge Robert Drain approved Purdue’s plan to resolve thousands of opioid lawsuits that drove it to insolvency.


Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart